Monday, October 05, 2009
Lab21 to market, sell DiagnoCure cancer test
QUEBEC CITY, Que. - Canadian life sciences company DiagnoCure Inc. (TSX:CUR) says its Previstage test for colorectal cancer will be represented in the United Kingdom and Ireland by a new partner, Lab21 of Cambridge, England....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment